Pacific Biosciences Of California (PACB) Non-Current Assets (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Non-Current Assets of $412.8 million for Q1 2026, down 0.73% year-over-year from $415.9 million in Q1 2025, and up 0.93% quarter-over-quarter from $409.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Non-Current Assets (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Non-Current Assets history runs 17 years deep, the most recent figure standing at $412.8 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 0.73% year-over-year to $412.8 million; the TTM figure through Mar 2026 stood at $1.6 billion (down 43.89% YoY), while the FY2025 annual figure was $409.0 million, down 46.52% from the prior year.
- Non-Current Assets for Q1 2026 stood at $412.8 million, up from $409.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $1.0 billion in Q3 2023, with the low at $408.9 million in Q3 2025.
- The 5-year median for Non-Current Assets is $905.1 million (2022), against an average of $767.3 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 1499.18% in 2022, then sank 58.12% in 2025.
- Pacific Biosciences Of California's Non-Current Assets stood at $915.0 million in 2022, then grew by 9.72% to $1.0 billion in 2023, then decreased by 23.83% to $764.8 million in 2024, then plunged by 46.52% to $409.0 million in 2025, then grew by 0.93% to $412.8 million in 2026.
- Business Quant data shows PACB's Non-Current Assets at $412.8 million in Q1 2026, $409.0 million in Q4 2025, and $408.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Pacific Biosciences Of California | 394.84 Mn | 157.97 Mn | 12.64 Mn | 413.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 413.21 Mn |
| Mar 31, 2026 | 412.85 Mn |
| Dec 31, 2025 | 409.03 Mn |
| Sep 30, 2025 | 408.92 Mn |
| Jun 30, 2025 | 412.07 Mn |
| Mar 31, 2025 | 415.87 Mn |
| Dec 31, 2024 | 764.77 Mn |
| Sep 30, 2024 | 865.82 Mn |
| Jun 30, 2024 | 881.35 Mn |
| Mar 31, 2024 | 992.90 Mn |
| Dec 31, 2023 | 1.00 Bn |
| Sep 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 912.08 Mn |
| Mar 31, 2023 | 915.31 Mn |
| Dec 31, 2022 | 915.01 Mn |
| Sep 30, 2022 | 905.05 Mn |
| Jun 30, 2022 | 905.86 Mn |
| Mar 31, 2022 | 907.48 Mn |
| Dec 31, 2021 | 905.84 Mn |
| Jun 30, 2021 | 56.65 Mn |